N-[4-(4-Amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]-methylesulfonamide
CAS: 532959-63-0
Ref. 3D-NA162905
1mg | 338,00 € | ||
5mg | 542,00 € | ||
10mg | 678,00 € | ||
25mg | 852,00 € | ||
50mg | 1.093,00 € |
Información del producto
N-{4-[4-amino-2-(ethyl)-1H-imidazo[4,5-c]quinolin-1-yl]butyl}methylesulfonamide (AEMI) is a novel immunomodulator that has been shown to have anticarcinogenic effects in preclinical studies. It induces an immune response in patients with cancer by stimulating the production of interleukin 1 receptor antagonist and other cytokines. AEMI also activates toll-like receptor 2, which is involved in the innate immunity pathway and triggers an orchestrated immune response to destroy tumour cells. The clinical response to AEMI is dose proportional and shows no adverse effects on healthy cells or tissues.
Propiedades químicas
Consulta técnica sobre: 3D-NA162905 N-[4-(4-Amino-2-ethyl-1H-imidazo[4,5-c]quinolin-1-yl)butyl]-methylesulfonamide
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.